The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model

@inproceedings{Larame2014TheCA,
  title={The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model},
  author={Philippe Laram{\'e}e and T H Brodtkorb and Nora Rahhali and Chris Knight and Carolina Duarte Barbosa and Cl{\'e}ment François and Mondher Toumi and Jean-Bernard Daeppen and J{\"u}rgen Rehm},
  booktitle={BMJ open},
  year={2014}
}
OBJECTIVES To determine whether nalmefene combined with psychosocial support is cost-effective compared with psychosocial support alone for reducing alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels (DRLs) as defined by the WHO, and to evaluate the public health benefit of reducing harmful alcohol-attributable… CONTINUE READING